Clinical And Laboratory Indicators Of Patients With Covid 19 In Uzbekistan

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/10026

Full metadata record

DC Field	Value	Language
dc.contributor.author	G.N. Sobirova, G.A. Jumayeva, M.R. Bekchanova, Z.O. Bafoyeva	-
dc.date.accessioned	2024-01-14T18:07:46Z	-
dc.date.available	2024-01-14T18:07:46Z	-
dc.date.issued	2023	-
dc.identifier.issn	2093-4777	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/10026	-
dc.description.abstract	A comparative analysis of clinical, anamnestic and laboratory parameters of patients with COVID-19 was carried out using the method of retrospective and prospective examination. It was found that during treatment with antiviral drugs, a quarter of patients had changes of cytolysis markers. It was also shown that patients with comorbidity were more common in a prospective study.	en_US
dc.language.iso	other	en_US
dc.publisher	International Neurourology Journal	en_US
dc.subject	Covid-19, retrospective study, prospective analysis, comorbidity.	en_US
dc.title	Clinical And Laboratory Indicators Of Patients With Covid 19 In Uzbekistan	en_US
dc.type	Article	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
Собирова ГН_скопус.pdf		326.82 kB	Adobe PDF	View/Open

DSpace JSPUI